ClinicalTrials.Veeva

Menu

Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19

M

Mohammed VI University Hospital

Status

Completed

Conditions

Obesity
COVID-19 Pandemic

Treatments

Device: Obesity

Study type

Observational

Funder types

Other

Identifiers

NCT05771857
Service anesthesie Reanimation

Details and patient eligibility

About

Our study has the objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19.

Full description

Introduction: COVID 19 pandemic continues to progress with a considerable mortality and morbidity throughout the world since its emergence in December 2019. Many studies were conducted to identify the predictive factors of mortality of those infected with the virus. The previous studies noticed that obesity seems to be associated with severe form of respiratory distress syndrome. Our study has the objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19.

Methods: investigators led a retrospective monocentric, descriptive and analytic study, in the department of anesthesia and intensive care unit of the university hospital of Mohamed VI Oujda, in Morocco, from March 2020 to October 2021, including all the patients tested positive for the infection.

Enrollment

415 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All patients presenting an infection with SARS-CoV-2 that were hospitalized in the intensive care unit.

Exclusion criteria

  • None

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems